Autopsy report · NCT01163526
Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies
Cause of deathSlow enrollment
“accrual”
Life of this trial
- Registered 2 months before it started.
- Ran for about 5 years 10 months before it stopped.
- 13 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- Stanford University
- Sponsor type
- University, hospital or other
- Conditions
- Neuroendocrine Tumors; Brain (Nervous System) Cancers; Colon/Rectal Cancer; Colon Cancer; Hepatobiliary Cancers; Hepatocellular Carcinoma (Hepatoma)
- Interventions
- CT perfusion
- Participants
- 13
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.